BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33735931)

  • 1. mpMRI of the Prostate (MR-Prostatography): Updated Recommendations of the DRG and BDR on Patient Preparation and Scanning Protocol.
    Franiel T; Asbach P; Beyersdorff D; Blondin D; Kaufmann S; Mueller-Lisse UG; Quentin M; Rödel S; Röthke M; Schlemmer HP; Schimmöller L; ;
    Rofo; 2021 Jul; 193(7):763-777. PubMed ID: 33735931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI of the Prostate: Recommendations on Patient Preparation and Scanning Protocol.
    Franiel T; Quentin M; Mueller-Lisse UG; Schimmoeller L; Asbach P; Rödel S; Willinek W; Hueper K; Beyersdorff D; Röthke M
    Rofo; 2017 Jan; 189(1):21-28. PubMed ID: 28002857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a 5-Minute Magnetic Resonance Imaging Screening Protocol for Prostate Cancer in Men With Elevated Prostate-Specific Antigen Before Biopsy.
    Weiss J; Martirosian P; Notohamiprodjo M; Kaufmann S; Othman AE; Grosse U; Nikolaou K; Gatidis S
    Invest Radiol; 2018 Mar; 53(3):186-190. PubMed ID: 29077588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
    Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
    Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More Than Detection of Adenocarcinoma - Indications and Findings in Prostate MRI in Benign Prostatic Disorders.
    Oerther B; Sigle A; Franiel T; Teichgräber U; Bamberg F; Gratzke C; Benndorf M
    Rofo; 2022 May; 194(5):481-490. PubMed ID: 35081650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition.
    Engels RRM; Israël B; Padhani AR; Barentsz JO
    Eur Urol; 2020 Apr; 77(4):457-468. PubMed ID: 31582290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statement of the German Roentgen Society, German Society of Neuroradiology, and Society of German-speaking Pediatric Radiologists on Requirements for the Performance and Reporting of MR Imaging Examinations Outside of Radiology.
    Hunold P; Bucher AM; Sandstede J; Janka R; Fritz LB; Regier M; Loose R; Barkhausen J; Mentzel HJ; Zimmer C; Antoch G; ; ;
    Rofo; 2021 Sep; 193(9):1050-1061. PubMed ID: 33831956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy.
    Hosseiny M; Shakeri S; Felker ER; Lu D; Sayre J; Ahuja P; Raman SS
    AJR Am J Roentgenol; 2020 Sep; 215(3):660-666. PubMed ID: 32755166
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic accuracy of biparametric versus multiparametric prostate MRI: assessment of contrast benefit in clinical practice.
    Zawaideh JP; Sala E; Shaida N; Koo B; Warren AY; Carmisciano L; Saeb-Parsy K; Gnanapragasam VJ; Kastner C; Barrett T
    Eur Radiol; 2020 Jul; 30(7):4039-4049. PubMed ID: 32166495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists' training.
    de Rooij M; Israël B; Tummers M; Ahmed HU; Barrett T; Giganti F; Hamm B; Løgager V; Padhani A; Panebianco V; Puech P; Richenberg J; Rouvière O; Salomon G; Schoots I; Veltman J; Villeirs G; Walz J; Barentsz JO
    Eur Radiol; 2020 Oct; 30(10):5404-5416. PubMed ID: 32424596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.
    Gómez Rivas J; Giganti F; Álvarez-Maestro M; Freire MJ; Kasivisvanathan V; Martinez-Piñeiro L; Emberton M
    Eur Urol Focus; 2019 Sep; 5(5):799-806. PubMed ID: 29525382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The primacy of multiparametric MRI in men with suspected prostate cancer.
    Richenberg J; Løgager V; Panebianco V; Rouviere O; Villeirs G; Schoots IG
    Eur Radiol; 2019 Dec; 29(12):6940-6952. PubMed ID: 31172275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Financing perspectives for multiparametric magnetic resonance prostatography].
    Wujciak D; Antoch G
    Radiologe; 2021 Sep; 61(9):825-828. PubMed ID: 34213621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.
    Falagario UG; Martini A; Wajswol E; Treacy PJ; Ratnani P; Jambor I; Anastos H; Lewis S; Haines K; Cormio L; Carrieri G; Rastinehad AR; Wiklund P; Tewari A
    Eur Urol Oncol; 2020 Oct; 3(5):700-704. PubMed ID: 31548130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI combined with PSA density in detecting clinically significant prostate cancer in patients with PSA serum levels of 4∼10ng/mL: Biparametric versus multiparametric MRI.
    Han C; Liu S; Qin XB; Ma S; Zhu LN; Wang XY
    Diagn Interv Imaging; 2020 Apr; 101(4):235-244. PubMed ID: 32063483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative Multiparametric Magnetic Resonance Imaging for Prostate Cancer: What's Next?
    Panebianco V; Barchetti G; Simone G; Del Monte M; Ciardi A; Grompone MD; Campa R; Indino EL; Barchetti F; Sciarra A; Leonardo C; Gallucci M; Catalano C
    Eur Urol; 2018 Jul; 74(1):48-54. PubMed ID: 29566957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparison of a fast 1.5-T biparametric with the 3.0-T multiparametric ESUR magnetic resonance imaging protocol as a triage test for men at risk of prostate cancer.
    Van Nieuwenhove S; Saussez TP; Thiry S; Trefois P; Annet L; Michoux N; Lecouvet F; Tombal B
    BJU Int; 2019 Mar; 123(3):411-420. PubMed ID: 30240059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection and localisation of primary prostate cancer using
    Kalapara AA; Nzenza T; Pan HYC; Ballok Z; Ramdave S; O'Sullivan R; Ryan A; Cherk M; Hofman MS; Konety BR; Lawrentschuk N; Bolton D; Murphy DG; Grummet JP; Frydenberg M
    BJU Int; 2020 Jul; 126(1):83-90. PubMed ID: 31260602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic-specific antigen density behavior according to multiparametric magnetic resonance imaging result.
    Morote J; Celma A; Diaz F; Regis L; Roche S; Mast R; Semidey ME; de Torres IM; Planas J; Trilla E
    Urol Oncol; 2020 May; 38(5):410-417. PubMed ID: 32067845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy.
    Sugano D; Sidana A; Jain AL; Calio B; Gaur S; Maruf M; Merino M; Choyke P; Turkbey B; Wood BJ; Pinto PA
    Int Urol Nephrol; 2020 Apr; 52(4):633-638. PubMed ID: 31807974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.